Clinical Trial Update: Induction Chemotherapy (R-CHOP Vs. R-FC) Followed by Interferon Maintenance Versus Rituximab Maintenance in MCL [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating induction regimens R-CHOP vs R-FC, followed by interferon maintenance versus rituximab maintenance in mantle cell lymphoma; status is u…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mantle Cell Lymphoma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Doxorubicin (doxorubicin)
• Fludarabine (Fludarabine)
• Interferon Alfa (interferon alfa)
• PREDNISONE (Prednisone)
• Rituximab (rituximab)
• Vincristine (vincristine)

Snippet

Sponsor: European Mantle Cell Lymphoma Network | Conditions: Lymphoma, Mantle-Cell | Phase 3 | Status: UNKNOWN